I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 6.73 USD -1.17% Market Closed
Market Cap: 434.6m USD

Wall Street
Price Targets

IMRX Price Targets Summary
Immuneering Corp

Wall Street analysts forecast IMRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMRX is 17.17 USD with a low forecast of 11.11 USD and a high forecast of 31.5 USD.

Lowest
Price Target
11.11 USD
65% Upside
Average
Price Target
17.17 USD
155% Upside
Highest
Price Target
31.5 USD
368% Upside
Immuneering Corp Competitors:
Price Targets
ALT
Altimmune Inc
387% Upside
SCLP
Scancell Holdings PLC
224% Upside
SLNO
Soleno Therapeutics Inc
143% Upside
ABBV
Abbvie Inc
9% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
90% Upside
2696
Shanghai Henlius Biotech Inc
69% Upside
PRME
Prime Medicine Inc
88% Upside
CCCC
C4 Therapeutics Inc
436% Upside

Revenue
Forecast

Revenue Estimate
Immuneering Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Immuneering Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Immuneering Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-59%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMRX's stock price target?
Price Target
17.17 USD

According to Wall Street analysts, the average 1-year price target for IMRX is 17.17 USD with a low forecast of 11.11 USD and a high forecast of 31.5 USD.

Back to Top